Your browser doesn't support javascript.
loading
Natural killer cells drive 4-1BBL positive uveal melanoma towards EMT and metastatic disease.
Neo, Shi Yong; Oliveira, Mariana M S; Tong, Le; Chen, Yi; Chen, Ziqing; Cismas, Sonia; Burduli, Nutsa; Malmerfelt, Anna; Teo, Joey Kay Hui; Lam, Kong-Peng; Alici, Evren; Girnita, Leonard; Wagner, Arnika K; Westerberg, Lisa S; Lundqvist, Andreas.
Afiliação
  • Neo SY; Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Singapore, Republic of Singapore.
  • Oliveira MMS; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Tong L; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
  • Chen Y; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Chen Z; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Cismas S; Department of Medicine, Division of Hematology and Oncology, Columbia University Irving Medical Center, New York, USA.
  • Burduli N; Department of Molecular Biology, Lewis Thomas Laboratory, Princeton University, Princeton, NJ, USA.
  • Malmerfelt A; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Teo JKH; Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.
  • Lam KP; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Alici E; Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Singapore, Republic of Singapore.
  • Girnita L; Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Singapore, Republic of Singapore.
  • Wagner AK; Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.
  • Westerberg LS; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Lundqvist A; Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.
J Exp Clin Cancer Res ; 43(1): 13, 2024 Jan 09.
Article em En | MEDLINE | ID: mdl-38191418
ABSTRACT

BACKGROUND:

Inflammation in the eye is often associated with aggravated ocular diseases such as uveal melanoma (UM). Poor prognosis of UM is generally associated with high potential of metastatic liver dissemination. A strong driver of metastatic dissemination is the activation of the epithelial-mesenchymal transition (EMT) regulating transcription factor ZEB1, and high expression of ZEB1 is associated with aggressiveness of UM. While ZEB1 expression can be also associated with immune tolerance, the underlying drivers of ZEB1 activation remain unclear.

METHODS:

Transcriptomic, in vitro, ex vivo, and in vivo analyses were used to investigate the impact on clinical prognosis of immune infiltration in the ocular tumor microenvironment. A metastatic liver dissemination model of was developed to address the role of natural killer (NK) cells in driving the migration of UM.

RESULTS:

In a pan-cancer TCGA analysis, natural killer (NK) cells were associated with worse overall survival in uveal melanoma and more abundant in high-risk monosomy 3 tumors. Furthermore, uveal melanoma expressed high levels of the tumor necrosis factor superfamily member 4-1BB ligand, particularly in tumors with monosomy 3 and BAP1 mutations. Tumors expressing 4-1BB ligand induced CD73 expression on NK cells accompanied with the ability to promote tumor dissemination. Through ligation of 4-1BB, NK cells induced the expression of the ZEB1 transcription factor, leading to the formation of liver metastasis of uveal melanoma.

CONCLUSIONS:

Taken together, the present study demonstrates a role of NK cells in the aggravation of uveal melanoma towards metastatic disease.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ligante 4-1BB / Melanoma Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ligante 4-1BB / Melanoma Idioma: En Ano de publicação: 2024 Tipo de documento: Article